PUBLISHED ON JAN 26, 2021 10:19 PM IST
Giving people ready-made antibodies can help those who are at high risk of severe disease because of weak immunity or underlying conditions.
By Bloomberg | Posted by Shivani Kumar
UPDATED ON NOV 24, 2020 04:21 AM IST
The drug, called REGN-COV2, received clearance from the US Food and Drug Administration for treatment of mild to moderate Covid-19 in adults and some children of at least 12 years of age.
By Bloomberg | Posted by Prashasti Singh
UPDATED ON NOV 22, 2020 07:34 AM IST
The treatment, administered to President Donald Trump after he contracted the coronavirus in October, consists of two monoclonal antibodies that target the spike protein used by the virus to enter cells. Trump was treated with the drug based on a compassionate-use request by his doctors.
By Press Trust of India | Posted by Kanishka Sarkar | New York
UPDATED ON OCT 10, 2020 02:18 PM IST
In the current study, published in the journal Science, the researchers tested REGN-COV2 in rhesus macaques, which manifest mild Covid-19 symptoms, and in golden hamsters, which show symptoms that are much more severe, including rapid weight loss.
By hindustantimes.com | Edited by Prashasti Singh | Hindustan Times, New Delhi
UPDATED ON OCT 09, 2020 08:30 AM IST
Donald Trump’s physician said the President’s blood samples from Monday show that he had protective antibodies, but according to the pharmaceutical company, those were likely the Regeneron antibodies.
By Dr Narinder Kumar Mehra
UPDATED ON OCT 07, 2020 08:12 AM IST
The Covid-19 era has witnessed unprecedented scientific collaboration. Several welcome possibilities have emerged and these have the potential to protect the highest-risk health care workers, while also lessening the severity of Covid-19 in hospitalised patients until the vaccine becomes available.
By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 30, 2020 05:23 AM IST
REGN-COV2 is part of a class of biotech therapies known as monoclonal antibodies. Several companies are using the technology to manufacture copies of human antibodies to the new coronavirus.
By Reuters | Reuters
PUBLISHED ON JUL 03, 2020 07:51 AM IST
Other drugs in the same class, including Roche Holding AG’s Actemra, are also being studied as treatments for Covid-19.